Product Information

TRAVOPROST 0.004% EYE DROP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $8.7425 per ML under NDC 00378965150. Its NADAC has been published 349 times since Mar 18, 2020.

FDA first approved this application on Jul 7, 2017. Its Orange Book therapeutic-equivalence code is AT2.

TRAVOPROST 0.004% EYE DROP

Travoprost Ophthalmic Solution, 0.004%
$8.7425per ML

Strength

.04 mg/mL

NDC

00378965150

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

TRAVOPROST

Approval Type

Generic (ANDA)

FDA Application

ANDA205050

FDA Approved

7/7/2017

TE Code

AT2

On Market Since

12/18/2019

Pharmacological Classes

Prostaglandin Analog
Prostaglandins

Price Statistics

The NADAC for TRAVOPROST 0.004% EYE DROP has been published 349 times since Mar 18, 2020, and over the history we have for it it has declined 82.6%. The table below summarizes its recorded NADAC range and movement.

Current price$8.7425 per ML
All-time high$50.2232 (Apr 15, 2020)
All-time low$8.4375 (Jul 22, 2026)
52-week high$10.7845
52-week low$8.4375
Median price$20.0467
Average price$24.4170
Largest weekly change+30.7% (Jun 19, 2024)
Weeks tracked349
Tracking sinceMar 18, 2020

Price History

1W

-7.1%

1M

-10.3%

3M

-6.3%

6M

-8.5%

1Y

-16.5%

3Y

-56.4%

5Y

-74.5%

All

-82.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRAVOPROST 0.004% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TRAVOPROST 0.004% EYE DROP, manufactured by Mylan Pharmaceuticals Inc., is $8.7425 per ML (NDC 00378965150), effective Nov 18, 2026.

How has the price of TRAVOPROST 0.004% EYE DROP changed over time?

Over the history we have for it, the NADAC for TRAVOPROST 0.004% EYE DROP has declined 82.6%. It has been tracked across 349 weekly CMS publications since Mar 18, 2020.

What are the highest and lowest recorded NADAC prices for TRAVOPROST 0.004% EYE DROP?

Since Mar 18, 2020, the NADAC for TRAVOPROST 0.004% EYE DROP has ranged from a low of $8.4375 (Jul 22, 2026) to a high of $50.2232 (Apr 15, 2020), with a median of $20.0467 per ML.

Are there cheaper alternatives to TRAVOPROST 0.004% EYE DROP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRAVOPROST 0.004% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures TRAVOPROST 0.004% EYE DROP?

TRAVOPROST 0.004% EYE DROP (NDC 00378965150) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.